Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.37 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.28, with a volume of 1,494,172 shares.
Northwest Biotherapeutics Stock Down 2.3 %
The firm has a market cap of $358.33 million, a price-to-earnings ratio of -3.44 and a beta of -0.55. The firm has a fifty day moving average price of $0.30 and a 200-day moving average price of $0.37.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Stories
- Five stocks we like better than Northwest Biotherapeutics
- Why Are These Companies Considered Blue Chips?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Trading Stocks: RSI and Why it’s Useful
- Applied Materials Market Capitulates: Now is the Time to Buy
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
